Copyright Reports & Markets. All rights reserved.

Global Liposomes Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Liposomes Market Overview

      • 1.1 Product Overview and Scope of Liposomes
      • 1.2 Liposomes Segment by Type
        • 1.2.1 Global Liposomes Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Liposomal Doxorubicin
        • 1.2.3 Liposomal Amphoteracin B
        • 1.2.4 Liposomal Paclitaxel
        • 1.2.5 Other
      • 1.3 Liposomes Segment by Application
        • 1.3.1 Liposomes Consumption Comparison by Application (2014-2025)
        • 1.3.2 Fungal Infection Therapy
        • 1.3.3 Cancer & Tumor Therapy
        • 1.3.4 Other
      • 1.4 Global Liposomes Market by Region
        • 1.4.1 Global Liposomes Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Liposomes Market Size
        • 1.5.1 Global Liposomes Revenue (2014-2025)
        • 1.5.2 Global Liposomes Production (2014-2025)

      2 Global Liposomes Market Competition by Manufacturers

      • 2.1 Global Liposomes Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Liposomes Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Liposomes Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Liposomes Production Sites, Area Served, Product Types
      • 2.5 Liposomes Market Competitive Situation and Trends
        • 2.5.1 Liposomes Market Concentration Rate
        • 2.5.2 Liposomes Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Liposomes Production Market Share by Regions

      • 3.1 Global Liposomes Production Market Share by Regions
      • 3.2 Global Liposomes Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Liposomes Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Liposomes Production
        • 3.4.1 North America Liposomes Production Growth Rate (2014-2019)
        • 3.4.2 North America Liposomes Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Liposomes Production
        • 3.5.1 Europe Liposomes Production Growth Rate (2014-2019)
        • 3.5.2 Europe Liposomes Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Liposomes Production (2014-2019)
        • 3.6.1 China Liposomes Production Growth Rate (2014-2019)
        • 3.6.2 China Liposomes Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Liposomes Production (2014-2019)
        • 3.7.1 Japan Liposomes Production Growth Rate (2014-2019)
        • 3.7.2 Japan Liposomes Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Liposomes Consumption by Regions

      • 4.1 Global Liposomes Consumption by Regions
      • 4.2 North America Liposomes Consumption (2014-2019)
      • 4.3 Europe Liposomes Consumption (2014-2019)
      • 4.4 China Liposomes Consumption (2014-2019)
      • 4.5 Japan Liposomes Consumption (2014-2019)

      5 Global Liposomes Production, Revenue, Price Trend by Type

      • 5.1 Global Liposomes Production Market Share by Type (2014-2019)
      • 5.2 Global Liposomes Revenue Market Share by Type (2014-2019)
      • 5.3 Global Liposomes Price by Type (2014-2019)
      • 5.4 Global Liposomes Production Growth by Type (2014-2019)

      6 Global Liposomes Market Analysis by Applications

      • 6.1 Global Liposomes Consumption Market Share by Application (2014-2019)
      • 6.2 Global Liposomes Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Liposomes Business

      • 7.1 Johnson & Johnson
        • 7.1.1 Johnson & Johnson Liposomes Production Sites and Area Served
        • 7.1.2 Liposomes Product Introduction, Application and Specification
        • 7.1.3 Johnson & Johnson Liposomes Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Gilead Sciences
        • 7.2.1 Gilead Sciences Liposomes Production Sites and Area Served
        • 7.2.2 Liposomes Product Introduction, Application and Specification
        • 7.2.3 Gilead Sciences Liposomes Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Pacira
        • 7.3.1 Pacira Liposomes Production Sites and Area Served
        • 7.3.2 Liposomes Product Introduction, Application and Specification
        • 7.3.3 Pacira Liposomes Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Sun Pharmaceutical
        • 7.4.1 Sun Pharmaceutical Liposomes Production Sites and Area Served
        • 7.4.2 Liposomes Product Introduction, Application and Specification
        • 7.4.3 Sun Pharmaceutical Liposomes Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Luye Pharma
        • 7.5.1 Luye Pharma Liposomes Production Sites and Area Served
        • 7.5.2 Liposomes Product Introduction, Application and Specification
        • 7.5.3 Luye Pharma Liposomes Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Sigma-Tau Group
        • 7.6.1 Sigma-Tau Group Liposomes Production Sites and Area Served
        • 7.6.2 Liposomes Product Introduction, Application and Specification
        • 7.6.3 Sigma-Tau Group Liposomes Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Fudan-Zhangjiang
        • 7.7.1 Fudan-Zhangjiang Liposomes Production Sites and Area Served
        • 7.7.2 Liposomes Product Introduction, Application and Specification
        • 7.7.3 Fudan-Zhangjiang Liposomes Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Teva Pharmaceutical
        • 7.8.1 Teva Pharmaceutical Liposomes Production Sites and Area Served
        • 7.8.2 Liposomes Product Introduction, Application and Specification
        • 7.8.3 Teva Pharmaceutical Liposomes Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 CSPC
        • 7.9.1 CSPC Liposomes Production Sites and Area Served
        • 7.9.2 Liposomes Product Introduction, Application and Specification
        • 7.9.3 CSPC Liposomes Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Novartis
        • 7.10.1 Novartis Liposomes Production Sites and Area Served
        • 7.10.2 Liposomes Product Introduction, Application and Specification
        • 7.10.3 Novartis Liposomes Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Kingond Pharm
      • 7.12 Spectrum Pharmaceuticals
      • 7.13 Shanghai New Asia

      8 Liposomes Manufacturing Cost Analysis

      • 8.1 Liposomes Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Liposomes
      • 8.4 Liposomes Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Liposomes Distributors List
      • 9.3 Liposomes Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Liposomes Market Forecast

      • 11.1 Global Liposomes Production, Revenue Forecast
        • 11.1.1 Global Liposomes Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Liposomes Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Liposomes Price and Trend Forecast (2019-2025)
      • 11.2 Global Liposomes Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Liposomes Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Liposomes Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Liposomes Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Liposomes Production, Revenue Forecast (2019-2025)
      • 11.3 Global Liposomes Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Liposomes Consumption Forecast (2019-2025)
        • 11.3.2 Europe Liposomes Consumption Forecast (2019-2025)
        • 11.3.3 China Liposomes Consumption Forecast (2019-2025)
        • 11.3.4 Japan Liposomes Consumption Forecast (2019-2025)
      • 11.4 Global Liposomes Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Liposomes Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Liposomes are spherical nano-sized bilayered vesicles or “bags” in which an aqueous volume is entirely closed within a membrane composed of lipid (fat) molecules, usually phospholipids. The components within the bilayer define the rigidity/ fluidity and charge of the bilayer.
        North America dominated the market with market share of 44.2% due to the high medical level. Following North America, Europe is the second largest market with market share of 36%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 12.85%.

        The global Liposomes market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Liposomes volume and value at global level, regional level and company level. From a global perspective, this report represents overall Liposomes market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Johnson & Johnson
        Gilead Sciences
        Pacira
        Sun Pharmaceutical
        Luye Pharma
        Sigma-Tau Group
        Fudan-Zhangjiang
        Teva Pharmaceutical
        CSPC
        Novartis
        Kingond Pharm
        Spectrum Pharmaceuticals
        Shanghai New Asia

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Liposomal Doxorubicin
        Liposomal Amphoteracin B
        Liposomal Paclitaxel
        Other

        Segment by Application
        Fungal Infection Therapy
        Cancer & Tumor Therapy
        Other

        Buy now